These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20724509)

  • 1. Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei.
    Reckseidler-Zenteno SL; Viteri DF; Moore R; Wong E; Tuanyok A; Woods DE
    J Med Microbiol; 2010 Dec; 59(Pt 12):1403-1414. PubMed ID: 20724509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant.
    Reckseidler SL; DeShazer D; Sokol PA; Woods DE
    Infect Immun; 2001 Jan; 69(1):34-44. PubMed ID: 11119486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.
    Dando SJ; Ipe DS; Batzloff M; Sullivan MJ; Crossman DK; Crowley M; Strong E; Kyan S; Leclercq SY; Ekberg JAK; St John J; Beacham IR; Ulett GC
    Infect Immun; 2016 Jul; 84(7):1941-1956. PubMed ID: 27091931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
    DeShazer D; Waag DM; Fritz DL; Woods DE
    Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition.
    Reckseidler-Zenteno SL; DeVinney R; Woods DE
    Infect Immun; 2005 Feb; 73(2):1106-15. PubMed ID: 15664954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of
    Burtnick MN; Dance DAB; Vongsouvath M; Newton PN; Dittrich S; Sendouangphachanh A; Woods K; Davong V; Kenna DTD; Saiprom N; Sengyee S; Hantrakun V; Wuthiekanun V; Limmathurotsakul D; Chantratita N; Brett PJ
    Microbiol Spectr; 2024 Mar; 12(3):e0332123. PubMed ID: 38299821
    [No Abstract]   [Full Text] [Related]  

  • 7. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
    Warawa J; Woods DE
    FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
    Popov SF; Kurilov VIa; Iakovlev AT
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis.
    Marchetti R; Dillon MJ; Burtnick MN; Hubbard MA; Kenfack MT; Blériot Y; Gauthier C; Brett PJ; AuCoin DP; Lanzetta R; Silipo A; Molinaro A
    ACS Chem Biol; 2015 Oct; 10(10):2295-302. PubMed ID: 26198038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei.
    Moore RA; Reckseidler-Zenteno S; Kim H; Nierman W; Yu Y; Tuanyok A; Warawa J; DeShazer D; Woods DE
    Infect Immun; 2004 Jul; 72(7):4172-87. PubMed ID: 15213162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of capsular polysaccharides expressed by Burkholderia mallei and Burkholderia pseudomallei.
    Heiss C; Burtnick MN; Wang Z; Azadi P; Brett PJ
    Carbohydr Res; 2012 Feb; 349():90-4. PubMed ID: 22221792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
    Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
    Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharides and virulence of Burkholderia pseudomallei.
    Sarkar-Tyson M; Thwaite JE; Harding SV; Smither SJ; Oyston PCF; Atkins TP; Titball RW
    J Med Microbiol; 2007 Aug; 56(Pt 8):1005-1010. PubMed ID: 17644705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.
    Woodman ME; Worth RG; Wooten RM
    PLoS One; 2012; 7(12):e52276. PubMed ID: 23251706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of quorum sensing in the pathogenicity of Burkholderia pseudomallei.
    Ulrich RL; DeShazer D; Brueggemann EE; Hines HB; Oyston PC; Jeddeloh JA
    J Med Microbiol; 2004 Nov; 53(Pt 11):1053-1064. PubMed ID: 15496380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.
    Bayliss M; Donaldson MI; Nepogodiev SA; Pergolizzi G; Scott AE; Harmer NJ; Field RA; Prior JL
    Carbohydr Res; 2017 Nov; 452():17-24. PubMed ID: 29024844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malleilactone Is a Burkholderia pseudomallei Virulence Factor Regulated by Antibiotics and Quorum Sensing.
    Klaus JR; Deay J; Neuenswander B; Hursh W; Gao Z; Bouddhara T; Williams TD; Douglas J; Monize K; Martins P; Majerczyk C; Seyedsayamdost MR; Peterson BR; Rivera M; Chandler JR
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735757
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Muangsombut V; Withatanung P; Srinon V; Chantratita N; Stevens MP; Blackwell JM; Korbsrisate S
    Front Cell Infect Microbiol; 2017; 7():350. PubMed ID: 28848712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.
    Cuccui J; Milne TS; Harmer N; George AJ; Harding SV; Dean RE; Scott AE; Sarkar-Tyson M; Wren BW; Titball RW; Prior JL
    Infect Immun; 2012 Mar; 80(3):1209-21. PubMed ID: 22252864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and function of the capsules of Burkholderia pseudomallei and their potential as therapeutic targets.
    Reckseidler-Zenteno SL; Moore R; Woods DE
    Mini Rev Med Chem; 2009 Feb; 9(2):265-71. PubMed ID: 19200030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.